Researchers fused the preS1 regions of hepatitis B virus genotypes B and C into a single recombinant antigen, enabling an ELISA that accurately quantifies preS1 antibodies in Chinese patients across both genotypes where existing commercial kits miss nearly one in five.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.